Insider Trade: Sumeet Gagneja Sold 363 Shares of Maxim Integrated Products, Inc. (MXIM); 10-15 Associates Trimmed Zoetis (ZTS) Position By $1.31 Million

February 17, 2018 - By Maria Brooks

10-15 Associates Inc decreased Zoetis Inc (ZTS) stake by 36.73% reported in 2017Q3 SEC filing. 10-15 Associates Inc sold 20,784 shares as Zoetis Inc (ZTS)’s stock rose 14.85%. The 10-15 Associates Inc holds 35,808 shares with $2.28M value, down from 56,592 last quarter. Zoetis Inc now has $38.85B valuation. The stock increased 1.57% or $1.23 during the last trading session, reaching $79.73. About 3.96 million shares traded or 57.94% up from the average. Zoetis Inc. (NYSE:ZTS) has risen 29.89% since February 17, 2017 and is uptrending. It has outperformed by 13.19% the S&P500.

Shares block amounting to around $22,214 U.S. Dollars was published in a report submitted to the D.C. based-SEC on February 20, 2018. According to which, Sumeet Gagneja, the VP and Principal Acct Officer of Maxim Integrated Products Inc also an insider of the Pinksheet-listed Maxim Integrated Products Inc had unloaded precisely 363 shares – ( at $61.2 per each share ). He owns 0.00% of the -company’s market cap or 10,168 shares.




Among 21 analysts covering Zoetis Inc (NYSE:ZTS), 16 have Buy rating, 0 Sell and 5 Hold. Therefore 76% are positive. Zoetis Inc had 74 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Tuesday, January 16 by Jefferies. The rating was initiated by Hilliard Lyons with “Buy” on Tuesday, June 20. The stock has “Neutral” rating by UBS on Friday, November 24. The firm earned “Buy” rating on Thursday, July 20 by Stifel Nicolaus. The firm has “Buy” rating by Deutsche Bank given on Tuesday, December 20. The stock has “Outperform” rating by BMO Capital Markets on Friday, September 11. On Friday, November 17 the stock rating was maintained by Cowen & Co with “Buy”. The stock has “Equal-Weight” rating by Morgan Stanley on Friday, November 3. The firm has “Buy” rating by Stifel Nicolaus given on Thursday, November 2. Stifel Nicolaus maintained the stock with “Buy” rating in Tuesday, January 16 report.

10-15 Associates Inc increased Metlife Inc (NYSE:MET) stake by 12,433 shares to 223,301 valued at $11.60M in 2017Q3. It also upped Enterprise Prods Partners L (NYSE:EPD) stake by 208,920 shares and now owns 307,705 shares. Merck & Co Inc (NYSE:MRK) was raised too.

Investors sentiment increased to 1.1 in Q3 2017. Its up 0.06, from 1.04 in 2017Q2. It increased, as 41 investors sold ZTS shares while 233 reduced holdings. 62 funds opened positions while 240 raised stakes. 440.74 million shares or 0.80% less from 444.27 million shares in 2017Q2 were reported. 7,025 were accumulated by Hall Laurie J Trustee. Old Mutual Customised Solutions (Proprietary) invested in 0.13% or 14,485 shares. Mitsubishi Ufj Trust Bk Corporation owns 977,845 shares. Garde Cap Inc reported 0.08% in Zoetis Inc. (NYSE:ZTS). First Personal reported 760 shares stake. Voya Limited Co has invested 0.72% in Zoetis Inc. (NYSE:ZTS). Raymond James & Associates stated it has 594,179 shares. New York-based Glg Ltd Limited Liability Company has invested 0.1% in Zoetis Inc. (NYSE:ZTS). Sumitomo Mitsui Asset Mgmt Ltd holds 129,473 shares or 0.13% of its portfolio. Alps Advisors holds 0% or 7,193 shares. Contravisory Inv Management has invested 0% in Zoetis Inc. (NYSE:ZTS). Geode Capital Management Ltd Company invested in 0.11% or 4.88 million shares. Etrade Cap Management Limited Company accumulated 28,627 shares. Whittier Trust Of Nevada Incorporated owns 1,094 shares. Mufg Americas invested 0.04% in Zoetis Inc. (NYSE:ZTS).

Investors sentiment decreased to 1.08 in 2017 Q3. Its down 0.10, from 1.18 in 2017Q2. It turned negative, as 38 investors sold Maxim Integrated Products, Inc. shares while 134 reduced holdings. 51 funds opened positions while 134 raised stakes. 250.01 million shares or 0.14% more from 249.67 million shares in 2017Q2 were reported. Gsa Capital Prns Llp reported 6,281 shares. X Mgmt Com Llc invested in 0.01% or 5,111 shares. Kames Public Lc reported 638,434 shares. Blackrock has invested 0.05% in Maxim Integrated Products, Inc. (NASDAQ:MXIM). Raymond James & Assocs invested 0.02% in Maxim Integrated Products, Inc. (NASDAQ:MXIM). Alyeska Inv L P accumulated 512,007 shares. Bnp Paribas Asset Mngmt reported 0% in Maxim Integrated Products, Inc. (NASDAQ:MXIM). Pensionfund Dsm Netherlands has 64,000 shares. Public Sector Pension Inv Board holds 0% of its portfolio in Maxim Integrated Products, Inc. (NASDAQ:MXIM) for 16,300 shares. California Employees Retirement System holds 707,469 shares. Tci Wealth Advisors Incorporated reported 0% of its portfolio in Maxim Integrated Products, Inc. (NASDAQ:MXIM). Bahl & Gaynor reported 1.03% stake. Voya Ltd Liability Corp stated it has 197,450 shares. Eqis Cap owns 31,258 shares or 0.08% of their US portfolio. Smith Salley & Associate holds 0.24% or 26,734 shares in its portfolio.

Among 30 analysts covering Maxim Integrated Products Inc. (NASDAQ:MXIM), 15 have Buy rating, 1 Sell and 14 Hold. Therefore 50% are positive. Maxim Integrated Products Inc. has $73 highest and $31 lowest target. $51.58’s average target is -15.80% below currents $61.26 stock price. Maxim Integrated Products Inc. had 85 analyst reports since July 24, 2015 according to SRatingsIntel. RBC Capital Markets maintained the shares of MXIM in report on Friday, October 13 with “Hold” rating. The firm earned “Hold” rating on Thursday, January 25 by RBC Capital Markets. Morgan Stanley maintained Maxim Integrated Products, Inc. (NASDAQ:MXIM) rating on Wednesday, December 13. Morgan Stanley has “Underweight” rating and $44 target. Stifel Nicolaus maintained Maxim Integrated Products, Inc. (NASDAQ:MXIM) on Monday, August 14 with “Buy” rating. The firm has “Market Perform” rating given on Friday, June 16 by Raymond James. On Friday, October 20 the stock rating was maintained by KeyBanc Capital Markets with “Overweight”. The firm has “Buy” rating by Stifel Nicolaus given on Tuesday, January 30. The firm earned “Equal-Weight” rating on Tuesday, January 30 by Morgan Stanley. Citigroup maintained it with “Neutral” rating and $50 target in Monday, October 23 report. Stifel Nicolaus maintained the shares of MXIM in report on Friday, January 22 with “Buy” rating.

The stock increased 0.08% or $0.05 during the last trading session, reaching $61.26. About 2.52 million shares traded or 1.80% up from the average. Maxim Integrated Products, Inc. (NASDAQ:MXIM) has risen 31.27% since February 17, 2017 and is uptrending. It has outperformed by 14.57% the S&P500.

Maxim Integrated Products, Inc. designs, develops, makes, and markets a range of linear and mixed-signal integrated circuits in the United States, China, rest of Asia, Europe, and internationally. The company has market cap of $17.23 billion. The firm also provides a range of high-frequency process technologies and capabilities for use in custom designs. It has a 45.99 P/E ratio. It serves automotive, communications and data center, computing, consumer, and industrial markets.

Since August 14, 2017, it had 0 buys, and 22 insider sales for $18.67 million activity. 5,000 shares were sold by Jain Vivek, worth $300,000 on Monday, January 29. Another trade for 25,000 shares valued at $1.56 million was sold by KIDDOO BRUCE E. Another trade for 54,000 shares valued at $3.22 million was sold by DOLUCA TUNC. Shares for $434,257 were sold by Loftus David. $183,950 worth of Maxim Integrated Products, Inc. (NASDAQ:MXIM) was sold by NEIL CHRISTOPHER J on Tuesday, January 2. Preeshl Bryan sold $56,412 worth of Maxim Integrated Products, Inc. (NASDAQ:MXIM) on Tuesday, August 15. $25,922 worth of stock was sold by Wright Mary Ann on Monday, September 11.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.